About this episode
Plus: Eli Lilly’s obesity pill gets approval, and will take on a rival from Novo Nordisk in the booming GLP-1 drug market. And the Trump Administration is expected to overhaul steel and aluminum tariffs. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ Minute Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ Minute Briefing
U.S. Stocks Fall for Third Straight Session
WSJ Minute Briefing
Huawei’s Criminal Trial Kicks Off in New York City
WSJ Minute Briefing
Stocks Fall as Oil Tops $100
WSJ Minute Briefing
U.S. Stocks Fall as Oil Prices Climb Toward $100
WSJ Minute Briefing